Want to see HK:0574 full AI Analyst Report?
Pa Shun International Holdings Limited (0574) AI Stock Analysis
Top Page
Pa Shun International Holdings Limited
(HKEX:0574)
The score is primarily weighed down by weak financial performance—persistent negative equity, recurring losses, and consistently negative operating/free cash flow. Technicals also remain soft with the price below key long-term moving averages and a negative MACD, with only a modest offset from a near-oversold RSI reading. Valuation is difficult to assess due to the negative P/E driven by losses and no dividend yield data.
Pa Shun International Holdings Limited (0574) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 35.83M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -1.4
- Beta (1Y)
- -0.14
- Revenue Growth
- 0.21%
- EPS Growth
- -2.33%
- Country
- Hong Kong
- Employees
- 108
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Pa Shun International Holdings Limited Business Overview & Revenue Model
Company Description
Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People's Republic of China. The company sells pharmaceutical products to wholesalers, hospitals, and...
Pa Shun International Holdings Limited Financial Statement Overview
Summary
Overall financial quality is weak: recurring net losses (including 2024–2025), persistently negative shareholders’ equity (2021–2025) indicating elevated solvency risk, and consistently negative operating/free cash flow across all years shown. While there were pockets of improvement (a 2023 rebound and positive operating profit/EBITDA in 2025), they have not translated into sustained profitability or cash generation.
Income Statement
28NegativeBalance Sheet
18Very NegativeCash Flow
12Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 86.81M | 86.81M | 86.55M | 129.43M | 71.78M | 85.91M |
| Gross Profit | 12.01M | 12.01M | 17.06M | 29.43M | 13.30M | 11.06M |
| EBITDA | 7.54M | 7.53M | 2.89M | 19.65M | -2.30M | -10.70M |
| Net Income | -15.86M | -15.86M | -15.31M | 2.35M | -43.38M | -330.40M |
Balance Sheet | ||||||
| Total Assets | 169.78M | 169.78M | 179.65M | 206.57M | 136.09M | 468.59M |
| Cash, Cash Equivalents and Short-Term Investments | 5.53M | 5.53M | 15.97M | 16.51M | 1.90M | 2.27M |
| Total Debt | 205.79M | 45.48M | 44.03M | 165.97M | 108.71M | 99.01M |
| Total Liabilities | 297.34M | 297.34M | 315.68M | 322.67M | 251.60M | 251.59M |
| Stockholders Equity | -148.04M | -148.04M | -136.04M | -116.10M | -115.52M | -58.50M |
Cash Flow | ||||||
| Free Cash Flow | -12.08M | -11.71M | -1.77M | -35.00M | -2.35M | -22.12M |
| Operating Cash Flow | -10.93M | -10.57M | -1.68M | -34.93M | -2.32M | -21.89M |
| Investing Cash Flow | -1.17M | -1.15M | -88.00K | -65.00K | 2.98M | 24.97M |
| Financing Cash Flow | 1.39M | 1.54M | 1.23M | 49.61M | -1.02M | -6.07M |
Pa Shun International Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0574, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 35.65 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0574.
Pa Shun International Holdings Limited Peers Comparison
Overall Rating
HK:023977Outperform
HK:361372Outperform
HK:095068Neutral
HK:089758.6Neutral
HK:045544Neutral- HK:057440Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:0239 | 77Outperform | HKD 774.43M | 7.76 | 13.59% | 7.44% | 10.63% | 39.44% |
| HK:3613 | 72Outperform | HKD 4.73B | 10.23 | 11.15% | 6.55% | -20.79% | -30.04% |
| HK:0950 | 68Neutral | HKD 606.50M | 3.64 | 8.02% | 5.61% | 7.05% | 22.46% |
| HK:0897 | 59Neutral | HKD 401.18M | 100.00 | 0.34% | ― | -8.30% | -44.44% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:0455 | 44Neutral | HKD 191.35M | -2.73 | -14.55% | ― | 12.89% | -2.56% |
| HK:0574 | 40Underperform | HKD 35.83M | -1.42 | 10.70% | ― | 0.21% | -2.33% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:0574 | Pa Shun International Holdings Limited | 0.02 | -0.02 | -55.00% | |
| HK:3613 | Beijing Tong Ren Tang Chinese Medicine Co | 5.65 | -2.58 | -31.38% | |
| HK:0455 | Tianda Pharmaceuticals Ltd. | 0.09 | -0.05 | -34.07% | |
| HK:0897 | Wai Yuen Tong Medicine Holdings Limited | 0.36 | -0.10 | -21.74% | |
| HK:0950 | Lee's Pharmaceutical Holdings Limited | 1.03 | -0.77 | -42.94% | |
| HK:0239 | Pak Fah Yeow International Limited | 2.48 | 0.25 | 11.09% |
Pa Shun International Holdings Limited Corporate Events
Pa Shun International Winding-Up Petition Hearing Adjourned as Share Suspension Continues
Pa Shun International Holdings Limited has announced that the court hearing of a winding-up petition against the company, originally referenced in earlier announcements, was held on 16 September 2026 and has been adjourned to 21 October 2026. The com...
Pa Shun Faces Winding-Up Petition Over Unpaid HK$8 Million Loan
Pa Shun International Holdings Limited has disclosed that a creditor has filed a winding-up petition in the Hong Kong High Court over the company’s failure to repay a HK$8 million loan, plus accrued interest, that was taken for general working...
Pa Shun Flags Delay in 2026 Interim Results as Receivers Control PRC Units
Pa Shun International Holdings Limited has warned that it will miss the statutory deadlines for publishing its interim results and sending its interim report for the six months to 30 June 2026, after receivers took control of its PRC subsidiaries and...
Pa Shun International’s Requisitioned EGM Dissolved as Share Trading Remains Suspended
Pa Shun International Holdings Limited, a Cayman Islands-incorporated investment holding company listed in Hong Kong under stock code 574, is overseen by a board led by Chairman and executive director Yuan Hongbing alongside two independent non-execu...
Pa Shun International warned on trading resumption and potential delisting risk
Pa Shun International Holdings has disclosed that the Stock Exchange of Hong Kong has issued formal resumption guidance setting out conditions that must be met before trading in the company’s shares can restart. The exchange is requiring the co...
Pa Shun International Shareholders Approve All AGM Resolutions Amid Director Vote Imbalance
Pa Shun International Holdings Limited reported that all resolutions put to shareholders at its adjourned annual general meeting on 7 July 2026 were approved by poll. Shareholders representing about 59% of the company’s issued share capital wer...
Pa Shun International Clarifies Board and Committee Structure
Pa Shun International Holdings Limited has disclosed an updated list of its directors and clarified their respective roles and functions on the board. The company confirms that its board comprises one executive director, chairman Yuan Hongbing, and t...
Pa Shun Faces Receivership Over Key Pharma Assets After Scheme Default
Pa Shun International Holdings has defaulted on a HK$10 million yearly payment due under its court-sanctioned scheme of arrangement, triggering enforcement of a debenture secured over assets of its key pharmaceutical subsidiary. The scheme, which had...
Pa Shun International Halts Trading Pending Inside Information Announcement
Pa Shun International Holdings Limited, a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange under stock code 574, has a board composed of executive, non-executive and independent non-executive directors in line with typical H...
Pa Shun International Adjourns AGM After Lack of Quorum, Resets for July 7
Pa Shun International Holdings Limited has adjourned its annual general meeting originally scheduled for June 30, 2026, after failing to reach a quorum within the first 30 minutes as required under its articles of association. The meeting has been re...
Pa Shun International’s Shareholder-Requisitioned EGM Dissolved for Lack of Quorum
Pa Shun International Holdings Limited, a Cayman Islands-incorporated company listed in Hong Kong, maintains a board composed of executive, non-executive and independent non-executive directors, consistent with governance norms for listed entities. T...
Pa Shun International Faces Winding-Up Petition Over HK$8 Million Loan Default
Pa Shun International Holdings Limited has disclosed that a creditor, Underdog Consulting Limited, has filed a winding-up petition in the Hong Kong High Court, alleging the company failed to repay a HK$8 million loan principal that fell due in Novemb...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 26, 2026